Literature DB >> 17039226

Diffuse large B-cell lymphoma: a heterogeneous group of non-Hodgkin lymphomas comprising several distinct clinicopathological entities.

P De Paepe1, C De Wolf-Peeters.   

Abstract

Diffuse large B-cell lymphoma (DLBCL) as defined by the World Health Organization (WHO) classification is clinically, morphologically and genetically a heterogeneous group of malignant proliferations of large lymphoid B cells. Over the last 6 years, several studies have been published improving our understanding of these lymphomas. These studies analyzed DLBCL by their gene expression profile, provided further information on some of the variants of DLBCL listed in the WHO classification and stressed the impact of the site of origin of these tumors. This review summarizes these recent data and explores their impact on the recognition of new clinicopathological lymphoma entities.

Entities:  

Mesh：

Year:  2006        PMID： 17039226     DOI： 10.1038/sj.leu.2404449

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


  36 in total

1.  Reciprocal expression of the endocytic protein HIP1R and its repressor FOXP1 predicts outcome in R-CHOP-treated diffuse large B-cell lymphoma patients.

Authors:  K K Wong; D M Gascoyne; P J Brown; E J Soilleux; C Snell; H Chen; L Lyne; C H Lawrie; R D Gascoyne; L M Pedersen; M B Møller; K Pulford; D Murphy; T M Green; A H Banham
Journal:  Leukemia       Date:  2013-07-25       Impact factor: 11.528

2.  Circulating microRNA-125b and microRNA-130a expression profiles predict chemoresistance to R-CHOP in diffuse large B-cell lymphoma patients.

Authors:  Wang Xin Yuan; Yang Xi Gui; Wang Na Na; Jiang Chao; Xigui Yang
Journal:  Oncol Lett       Date:  2015-11-05       Impact factor: 2.967

3.  Lack of prognostic significance of the germinal-center phenotype in diffuse large B-cell lymphoma patients treated with CHOP-like chemotherapy with and without rituximab.

Authors:  Ivana Ilić; Zdravko Mitrović; Igor Aurer; Sandra Bašić-Kinda; Ivo Radman; Radmila Ajduković; Boris Labar; Snježana Dotlić; Marin Nola
Journal:  Int J Hematol       Date:  2009-06-03       Impact factor: 2.490

Review 4.  Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive review.

Authors:  Rosalba Camicia; Hans C Winkler; Paul O Hassa
Journal:  Mol Cancer       Date:  2015-12-11       Impact factor: 27.401

5.  Immunostaining to identify molecular subtypes of diffuse large B-cell lymphoma in a population-based epidemiologic study in the pre-rituximab era.

Authors:  Lindsay M Morton; James R Cerhan; Patricia Hartge; Mohammad A Vasef; Vishala T Neppalli; Yasodha Natkunam; Ahmet Dogan; Bhavana J Dave; Smrati Jain; Ronald Levy; Izidore S Lossos; Wendy Cozen; Scott Davis; Mary Jean Schenk; Matthew J Maurer; Charles F Lynch; Nathaniel Rothman; Nilanjan Chatterjee; Kai Yu; Louis M Staudt; Dennis D Weisenburger; Sophia S Wang
Journal:  Int J Mol Epidemiol Genet       Date:  2011-07-05

6.  A case of plasmablastic lymphoma of the liver without human immunodeficiency virus infection.

Authors:  Joji Tani; Hisaaki Miyoshi; Takako Nomura; Hirohito Yoneyama; Hideki Kobara; Hirohito Mori; Asahiro Morishita; Takashi Himoto; Tsutomu Masaki
Journal:  World J Gastroenterol       Date:  2013-10-07       Impact factor: 5.742

7.  Loss of p73 promotes dissemination of Myc-induced B cell lymphomas in mice.

Authors:  Alice Nemajerova; Oleksi Petrenko; Lorenz Trümper; Gustavo Palacios; Ute M Moll
Journal:  J Clin Invest       Date:  2010-05-17       Impact factor: 14.808

8.  Clinical significance and functional validation of inorganic pyrophosphatase in diffuse large B cell lymphoma in humans.

Authors:  Limei Li; Dehong Luo; Arong Jin
Journal:  Cytotechnology       Date:  2017-12-12       Impact factor: 2.058

9.  Gastrointestinal B-cell lymphomas: From understanding B-cell physiology to classification and molecular pathology.

Authors:  Xavier Sagaert; Thomas Tousseyn; Rhonda K Yantiss
Journal:  World J Gastrointest Oncol       Date:  2012-12-15

10.  Identification and functional relevance of de novo DNA methylation in cancerous B-cell populations.

Authors:  Xiao-Ming Wang; Timothy C Greiner; Marina Bibikova; Brian L Pike; Kimberly D Siegmund; Uttam K Sinha; Markus Müschen; Erich B Jaeger; Dennis D Weisenburger; Wing C Chan; Darryl Shibata; Jian-Bing Fan; Joseph G Hacia
Journal:  J Cell Biochem       Date:  2010-03-01       Impact factor: 4.429
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.